| 2026-08-06 | Press release | Evolent Announces Second Quarter 2026 Results |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-08 | Press release | Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 |
| 2026-06-04 | Proxy | 2026 Broadridge Broker Notice |
| 2026-06-04 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-07 | Press release | Evolent Announces First Quarter 2026 Results |
| 2026-05-07 | Press release | Press release · Q1 2026 · May 2026 |
| 2026-05-07 | Deck | Earnings presentation · Q1 2026 · May 2026 |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-24 | Proxy | Definitive proxy statement |
| 2026-04-07 | Press release | Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 |
| 2026-03-19 | Press release | Evolent announces appointment of Archie Mayani as chief product officer |
| 2026-02-26 | Press release | Evolent to Participate in Upcoming Investor Conferences |
| 2026-02-25 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-24 | Press release | Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results |
| 2026-02-24 | Press release | Press release · Q4 2025 · Feb 2026 |
| 2026-02-24 | Deck | Investor presentation · Q4 2025 · Feb 2026 |
| 2026-02-24 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-04 | Press release | Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 |
| 2026-01-02 | Press release | Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 |
| 2025-12-08 | 8-K | Form 8-K, Item 8.01 |
| 2025-12-02 | 8-K | Form 8-K, Item 5.02 |
| 2025-11-07 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-11-06 | Press release | Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior aut |
| 2025-11-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-09 | Press release | Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 |
| 2025-09-23 | Press release | Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners · Q3 2025 |
| 2025-09-23 | 8-K | Form 8-K, Item 7.01 |
| 2025-08-21 | 8-K | Form 8-K, Item 1.01 |
| 2025-08-19 | 8-K | Form 8-K, Item 8.01 |
| 2025-08-18 | 8-K | Form 8-K, Item 8.01 |
| 2025-08-11 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-08-07 | 8-K | Form 8-K, Item 2.02 results |
| 2025-07-14 | Press release | Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 |
| 2025-06-20 | 8-K | Form 8-K, Item 1.01 |
| 2025-06-05 | 8-K | Form 8-K, Item 5.02 |
| 2025-06-03 | 8-K | Form 8-K, Item 7.01 |
| 2025-05-09 | 10-Q | Form 10-Q for the quarter ended Mar 31 |